Stock TOVX THERIVA BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Theriva Biologics, Inc.

Equities

TOVX

US87164U4094

Delayed Nyse
Other stock markets
 17:53:41 17/05/2024 BST 		5-day change 1st Jan Change
0.3796 USD +1.48% Intraday chart for Theriva Biologics, Inc. +4.29% -11.74%
05-07 Theriva Biologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-23 Theriva Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Initiates Coverage on Synthetic Biologics With Overweight Rating
MT
History shows stocks can weather rate hike cycle
RE
SYNTHETIC BIOLOGICS : Maxim Upgrades Synthetic Biologics to Buy From Hold; Price Target is $2.50
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TOVX Stock
  4. News Theriva Biologics, Inc.
  5. Analyst Reco.